跳至主要内容
临床试验/DRKS00032698
DRKS00032698招募中不适用

Characterization of bioactive lipids in selected immune cell populations of leukemia patients and their influence on disease progression: a clinically prospective lipidomics approach

Carl von Ossietzky Universität Oldenburg, Fakultät VI, Abt. Pharmakologie & Toxikologie0 个研究点目标入组 120 人开始时间: 2024年6月5日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
120

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 one(—)
性别
All

入选标准

  • Patients with newly diagnosed AML and ALL who have actively consented to the study.

排除标准

  • The following patients are excluded:
  • Children, persons who are unable to give consent to the study, pregnant women, patients treated exclusively in palliative care and patients who receive or actively seek a hospice place as well as patients after bone marrow transplantation and under CAR-T cell therapy

研究者

发起方
Carl von Ossietzky Universität Oldenburg, Fakultät VI, Abt. Pharmakologie & Toxikologie

相似试验